EP Patent

EP1863458B2 — Solvent system for enhancing the solubility of pharmaceutical agents

Assigned to Patheon Softgels Inc · Expires 2022-03-02 · 4y expired

What this patent protects

Patent listed against naproxen-sodium.

Drugs covered by this patent

naproxen-sodium (NAPROXEN SODIUM)

Patent Metadata

Patent number: EP1863458B2
Jurisdiction: EP
Classification: —
Expires: 2022-03-02
Drug substance claim: No
Drug product claim: No
Assignee: Patheon Softgels Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.